Acquiring Company
Harrow
Acquired Company
Melt Pharmaceuticals
NashvilleBrentwoodBiotechnologyHealthcareHealth CarePharmaceuticalManufacturingHealthcareHealth CareDescription
Harrow has completed the acquisition of Melt Pharmaceuticals, focusing on advancing non-opioid sedation solutions. This strategic move enhances Harrow's portfolio with Melt's innovative drug candidates, including MELT-300, which aims to improve patient care in various medical procedures. The acquisition reflects Harrow's commitment to reducing opioid exposure while expanding sedation options across healthcare.
Quick answer
Harrow is acquiring Melt Pharmaceuticals, announced November 18, 2025. Harrow is based in Nashville, Tennessee, United States.
- How much did Harrow pay for Melt Pharmaceuticals?
- The deal value was not disclosed.
- What does Harrow do?
- Harrow (NASDAQ: HROW) is a growing leader in the ophthalmic healthcare market, dedicated to innovation and providing affordable, accessible medications.
- Where are Harrow and Melt Pharmaceuticals based?
- Harrow is based in Nashville, Tennessee, United States. Melt Pharmaceuticals is based in Brentwood, Tennessee, United States.
- Who are the decision-makers at Harrow?
- Fundz holds 2 contacts at Harrow. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AbbVie acquires Bretisilocin for mental health expansion (October 15, 2025)
- SAI Parenterals acquires majority stake in Noumed (December 5, 2025)
- ClearPoint Neuro acquires IRRAS for $5 million, $5M (November 20, 2025)
- Galecto, Inc. Acquires Damora Therapeutics, Inc. (November 10, 2025)
- MannKind acquires scPharmaceuticals to boost growth (October 7, 2025)
- Sanofi acquires Dynavax Technologies for $15.50/share (December 24, 2025)
Who to call at Harrow, and when
When Harrow changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Harrow raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Harrow, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Harrow. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Harrow makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Melt Pharmaceuticals?
Melt Pharmaceuticals was acquired by Harrow, based in Nashville. The deal was reported on November 18, 2025. Harrow (NASDAQ: HROW) is a growing leader in the ophthalmic healthcare market, dedicated to innovation and providing affordable, accessible medications. Harrow is publicly traded (HROW) and operates in Biotechnology.
When did Harrow acquire Melt Pharmaceuticals?
Harrow's acquisition of Melt Pharmaceuticals was reported on November 18, 2025. Harrow has completed the acquisition of Melt Pharmaceuticals, focusing on advancing non-opioid sedation solutions. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Melt Pharmaceuticals do?
Melt Pharmaceuticals, Inc. It is privately held, operating in Manufacturing, and is based in Brentwood.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.